Ventyx Biosciences logo

Ventyx Biosciences Share Price Today

(NASDAQ: VTYX)

Ventyx Biosciences share price is $1.52 & ₹132.19 as on 6 Mar 2025, 2.30 'hrs' IST

$1.52

0.06

(4.11%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Ventyx Biosciences share price in Dollar and Rupees. Guide to invest in Ventyx Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Ventyx Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Ventyx Biosciences share price movements

  • Today's Low: $1.44
    Today's High: $1.53

    Day's Volatility :5.64%

  • 52 Weeks Low: $1.37
    52 Weeks High: $11.48

    52 Weeks Volatility :88.07%

Ventyx Biosciences (VTYX) Returns

PeriodVentyx Biosciences, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-39.44%
3.7%
0.0%
6 Months
-29.95%
-2.8%
0.0%
1 Year
-83.02%
2.5%
0.0%
3 Years
-88.42%
12.9%
-11.6%

Ventyx Biosciences (VTYX) Key Statistics

in dollars & INR

Previous Close
$1.46
Open
$1.48
Today's High
$1.526
Today's Low
$1.44
Market Capitalization
$108.1M
Today's Volume
$602.4K
52 Week High
$11.48
52 Week Low
$1.37
Revenue TTM
$0.0
EBITDA
$-148.2M
Earnings Per Share (EPS)
$-1.97
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.27%

How to invest in Ventyx Biosciences Stock (VTYX) from India?

It is very easy for Indian residents to invest directly in Ventyx Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Ventyx Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Ventyx Biosciences or VTYX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Ventyx Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Ventyx Biosciences shares which would translate to 0.572 fractional shares of Ventyx Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Ventyx Biosciences, in just a few clicks!

Returns in Ventyx Biosciences (VTYX) for Indian investors in Rupees

The Ventyx Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ventyx Biosciences investment value today

Current value as on today

₹21,932

Returns

₹78,068

(-78.07%)

Returns from Ventyx Biosciences Stock

₹83,017 (-83.02%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Ventyx Biosciences (VTYX)

-30%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Ventyx Biosciences Stock from India on INDmoney has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Ventyx Biosciences

  • BlackRock Inc

    6.33%

  • Citadel Advisors Llc

    6.30%

  • Bank of America Corp

    6.01%

  • Sio Capital Management, LLC

    5.69%

  • UBS Group AG

    5.32%

  • Vanguard Group Inc

    4.93%

Analyst Recommendation on Ventyx Biosciences

Buy

    68%Buy

    31%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Ventyx Biosciences(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
8
Hold
5
5
8
Sell
0
0
0

Analyst Forecast on Ventyx Biosciences Stock (VTYX)

What analysts predicted

Upside of 689.47%

Target:

$12.00

Current:

$1.52

Insights on Ventyx Biosciences Stock (Ticker Symbol: VTYX)

  • Price Movement

    In the last 7 days, VTYX stock has moved up by 4.8%
  • VTYX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 149.5%
  • VTYX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 140.3%

Ventyx Biosciences Technicals Summary

Sell

Neutral

Buy

Ventyx Biosciences is currently in a neutral trading position according to technical analysis indicators.

Ventyx Biosciences (VTYX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ventyx Biosciences, Inc. logo
-17.39%
-29.95%
-83.02%
-88.42%
-92.77%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ventyx Biosciences, Inc. logo
NA
NA
NA
-2.01
-0.54
-0.33
NA
3.57
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ventyx Biosciences, Inc. logo
Buy
$108.1M
-92.77%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Ventyx Biosciences

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.
Organization
Ventyx Biosciences
Employees
79
CEO
Dr. Raju S. Mohan Ph.D.
Industry
Services

Management People of Ventyx Biosciences

NameTitle
Dr. Sheila K. Gujrathi M.D.
Executive Chairperson
Dr. Raju S. Mohan Ph.D.
Founder, CEO, President & Director
Dr. John M. Nuss Ph.D.
Chief Scientific Officer
Mr. Roy M. Gonzales CPA, M.B.A.
Senior VP of Finance and Principal Financial & Accounting Officer
Mr. Matthew Richard Moore
Chief Operating Officer
Dr. Mark S. Forman M.D., Ph.D.
Chief Medical Officer
Ms. Snehal Naik Ph.D.
Senior VP of Clinical Development
Mr. Kye Gilder M.D.
SVP of Biometrics - Biostatistics, Data Management, Statistical Programming, Medical Writing
Ms. Kathy Ogilvie Ph.D.
Senior VP of Translational & Nonclinical Research
Ms. Rosa Ferrao
Senior VP of Regulatory Affairs

Important FAQs about investing in VTYX Stock from India :

What is Ventyx Biosciences share price today?

Ventyx Biosciences share price today stands at $1.52, Open: $1.48 ; Previous Close: $1.46 ; High: $1.53 ; Low: $1.44 ; 52 Week High: $11.48 ; 52 Week Low: $1.37.

The stock opens at $1.48, after a previous close of $1.46. The stock reached a daily high of $1.53 and a low of $1.44, with a 52-week high of $11.48 and a 52-week low of $1.37.

Can Indians buy Ventyx Biosciences shares?

Yes, Indians can invest in the Ventyx Biosciences (VTYX) from India.

With INDmoney, you can buy Ventyx Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Ventyx Biosciences at zero transaction cost.

How can I buy Ventyx Biosciences shares from India?

It is very easy to buy Ventyx Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Ventyx Biosciences (VTYX) be purchased?

Yes, you can buy fractional shares of Ventyx Biosciences with INDmoney app.

What are the documents required to start investing in Ventyx Biosciences stocks?

To start investing in Ventyx Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Ventyx Biosciences Stock (VTYX)?

Today’s highest price of Ventyx Biosciences (VTYX) is $1.53.

Today’s lowest price of Ventyx Biosciences (VTYX) is $1.44.

What is today's market capitalisation of Ventyx Biosciences?

Today's market capitalisation of Ventyx Biosciences VTYX is 108.1M

What is the 52 Week High and Low Range of Ventyx Biosciences Stock (VTYX)?

  • 52 Week High

    $11.48

  • 52 Week Low

    $1.37

What are the historical returns of Ventyx Biosciences (VTYX)?

  • 1 Month Returns

    -17.39%

  • 3 Months Returns

    -29.95%

  • 1 Year Returns

    -83.02%

  • 5 Years Returns

    -92.77%

Who is the Chief Executive Officer (CEO) of Ventyx Biosciences ?

Dr. Raju S. Mohan Ph.D. is the current Chief Executive Officer (CEO) of Ventyx Biosciences.